Comparison

MAT2A-IN-7 European Partner

Item no. HY-144185-1ea
Manufacturer MedChem Express
CASRN 2756458-77-0
Amount 1 ea
Quantity options 100 mg 1 ea
Category
Type Chemicals
Specific against other
Formula C17H13ClF3N3O2
Citations [1]Li Zhen, et al. Bicyclic compounds. Patent WO2021254529A1.
Smiles O=C1N(C2=CC=CC=C2Cl)C3=C(C=CC(C(F)(F)F)=N3)C(NC)=C1OC
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Available
Product Description
MAT2A-IN-7 is a potent inhibitor of MAT2A. The expression level of MAT2A is abnormally elevated in several types of tumors, including gastric, colon, liver and pancreatic cancers. MAT2A-IN-7 reduces the proliferative activity of MTAP-deficient cancer cells. MAT2A-IN-7 has the potential for the potential for the research of cancer diseases (extracted from patent WO2021254529A1, compound 24)[1].
Shipping
Room temperature
Manufacturers Applications
Cancer-programmed cell death
MolecularWeight
383.75
Clinical Information
No Development Reported
Manufacturers Research Area
Cancer
Solubility
10 mM in DMSO
Target
Methionine Adenosyltransferase (MAT)
Manufacturers Target
Methionine Adenosyltransferase (MAT)
Manufacturers Pathway
Epigenetics; Metabolic Enzyme/Protease
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 ea
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close